| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jun―26 |
Ivabradine in the Treatment of POTS Before and After COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
Syeda Hafsa Qadri, Ana Beatriz Nardelli da Silva, Andela Malaj, Rohma Ahmed, Syeda Fizza Qadri, FNU Wajeeha, Praveen Kasina, Roshni Riaz Memon, Haris Muhammad, Muhammed Muzammil Jumani, Vicky Kumar |
| 2 |
[GO] |
2025―Jul―24 |
Rare but Severe Cardiovascular Complications of SARS-CoV-2 Vaccination: A Call for Awareness |
Michele Marchetta, Michele Golino, John D. Markley, Antonio Abbate |
| 3 |
[GO] |
2023―Apr―24 |
JCEHP-21-0367Postural Orthostatic Tachycardia Syndrome After COVID-19: a Systematic Review of Therapeutic Interventions |
Gerardina Abbate, Beatrice De Iulio, Georgia Thomas, Anna Priday, Giuseppe Biondi-Zoccai, Roshanak Markley, Antonio Abbate |
| 4 |
[GO] |
2022―Aug―23 |
Imatinib as a tool against Covid-19: a balancing act between effectiveness and cardiac safety |
Luigi Spadafora, Marco Bernardi, Giuseppe Biondi-Zoccai, Mariangela Peruzzi |
| 5 |
[GO] |
2022―Aug―17 |
Cardiac safety of imatinib for the treatment of Covid-19: a secondary analysis of a randomised, double blind, placebo-controlled trial |
E. Duijvelaar, A. Vanhove, J.R. Schippers, P.J. Smeele, F.S. de Man, Y. Pinto, J. Aman, H.J. Bogaard |
| 6 |
[GO] |
2022―Jul―05 |
Remdesivir (VEKLURY) for treating COVID-19: Guinea pig ex vivo and in vivo cardiac electrophysiological effects |
Sylvie Pilote, Chantale Simard, Benoit Drolet |
| 7 |
[GO] |
2021―Dec―22 |
Can epigenetics help solve the puzzle between concomitant cardiovascular injury and severity of COVID-19? |
Cássia L. Braga, Mariana Acquarone, Victor da C Arona, Brenno S. Osório, Thiago G. Barreto, Ruan M. Kian, João P. A. L. Pereira, Marina de Moraes C da Silva, Bagnólia A. Silva, Gláucia Maria M. de Oliveira, Patricia Rieken Macedo Rocco, Pedro Leme Silva, Allan K. N. Alencar |
| 8 |
[GO] |
2021―Dec―04 |
Renin-angiotensin System Blocker in COVID-19. A Single Center Study. |
Riya Job, Mohamed Abdul Qader, Pedro Torres, Baher AL Abbasi, Nakeya Dewaswala, Ahmed Abdallah, Kai Chen, Jesus E. Pino, Robert D. Chait |
| 9 |
[GO] |
2021―Oct―01 |
Calcium channel blockers and the risk of all-cause mortality and severe illness in patients with COVID-19 |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 10 |
[GO] |
2021―Jul―29 |
The role of hypertension on the severity of COVID-19 |
Mei Peng., Jia He ., Ying Xue., Xue Yang ., Shao Liu, Zhicheng Gong |
| 11 |
[GO] |
2021―Jun―26 |
Pre-admission statin therapy and clinical outcome in hospitalized patients with COVID-19 |
Vincenzo Russo, Angelo Silverio, Fernando Scudiero, Emilio Attena, Antonello D’Andrea, Luigi Nunziata, Guido Parodi, Dario Celentani, Ferdinando Varbella, Stefano Albani, Giuseppe Musumeci, Pierpaolo Di Micco, Marco Di Maio |
| 12 |
[GO] |
2021―Jun―26 |
Diabetes and COVID-19 |
Ali A. Rizvi, Andrei Janez, Wael Al Mahmeed, Manfredi Rizzo |
| 13 |
[GO] |
2021―May―18 |
Could dapagliflozin attenuate COVID-19 progression in high-risk patients with or without diabetes? Behind DARE-19 concept |
Anastasiou G, Hatziagelaki E, Liberopoulos E |
| 14 |
[GO] |
2020―Dec―05 |
Is spironolactone the preferred renin-angiotensin-aldosterone inhibitor for protection against COVID-19? |
Christopher S. Wilcox, Bertram Pitt |
| 15 |
[GO] |
2020―Oct―20 |
TARGETING THE VASCULAR ENDOTHELIUM IN THE TREATMENT OF COVID-19 |
Tatsiana Suvorava, Wayne Kaesemeyer |
| 16 |
[GO] |
2020―Oct―07 |
Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience |
Vincenzo Russo, Giuseppe Cardillo, Giuseppe Vito Viggiano, Sara Mangiacapra, Antonella Cavalli, Andrea Fontanella, Federica Agrusta, Annamaria Bellizzi, Maria Amitrano, Mariateresa Iannuzzo, Chiara Sacco, Corrado Lodigiani, Pierpaolo Di Micco |
| 17 |
[GO] |
2020―Sep―05 |
In-hospital management and outcomes of acute myocardial infarction before and during the coronavirus disease 2019 pandemic |
Bing Huang, Changwu Xu, Huafen Liu, Wei Deng, Zheng Yang, Jun Wan, Hui Yan, Guiqiu Cao, Jing Chen, Hong Jiang |
| 18 |
[GO] |
2020―Aug―08 |
The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection |
Antonis S. Manolis, Theodora A. Manolis, Antonis A. Manolis, Helen Melita |
| 19 |
[GO] |
2020―Jun―22 |
Current Perspectives of Anticoagulation in Patients with COVID-19 |
Elizabeth M. Gavioli, Gabriela Sikorska, Ammy Man, Jay Rana, Etty Vider |
| 20 |
[GO] |
2020―May―26 |
Atrial Fibrillation in COVID-19 |
Vincenzo Russo, Anna Rago, Andreina Carbone, Roberta Bottino, Ernesto Ammendola, Nadia Della Cioppa, Dario Galante, Paolo Golino, Gerardo Nigro |
| 21 |
[GO] |
2020―Apr―16 |
Cardiovascular Pharmacology in the Time of COVID-19 |
Leo F. Buckley, Judy W.M. Cheng, Akshay Desai |
| 22 |
[GO] |
2020―Apr―10 |
Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19) |
Dave L. Dixon, Benjamin W. Van Tassell, Alessandra Vecchié, Aldo Bonaventura, Azita Talasaz, Hesam Kakavand, Fabrizio D’Ascenzo, Antonio Perciaccante, Davide Castagno, Enrico Ammirati, Giuseppe Biondi-Zoccai, Michael Stevens, Antonio Abbate |
|
